Bedside detection of the signatures of heart disease
A disposable point-of-care device has been designed that can detect cardiac troponin I (cTnI) – a biomarker that is highly specific to cardiac injury. The approach uses a surface acoustic wave immunosensor packaged within a disposable microfluidic cartridge that can test for cTnI in the blood. The new test is comparable in terms of accuracy and sensitivity to laboratory-based methods.
Cardiac biomarkers are extremely important for diagnosing cardiac illness, including acute myocardial infection, which can often be fatal. Delays in diagnosis and treatment can seriously affect a patient’s outcome, making point-of-care devices a valuable resource.
Original publication
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.